Dividend yield | 3.43% |
Last dividend (FY24) | NZD1.30 |
Revenue growth (TTM) Revenue growth | 6.61% |
Revenue (TTM) Revenue | NZD14.26b |
EBIT (operating result TTM) EBIT | NZD522.37m |
Free Cash Flow (TTM) Free Cash Flow | NZD272.87m |
EPS (TTM) EPS | NZD1.53 |
P/E forward | 24.31 |
P/S forward | 0.55 |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
Jun '24 |
+/-
%
|
||
Revenue | 14,257 14,257 |
7%
7%
|
|
Gross Profit | 1,034 1,034 |
3%
3%
|
|
EBITDA | 662 662 |
6%
6%
|
EBIT (Operating Income) EBIT | 522 522 |
7%
7%
|
Net Profit | 294 294 |
6%
6%
|
In millions NZD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. It operates through the following segments: Healthcare, Animal Care, and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities. The Animal Care segment sells animal care products in a range of sectors, own brands, retail and wholesale activities. The Corporate segment includes net funding costs and central administration expenses. The company was founded on September 11, 1922 and is headquartered in Christchurch, New Zealand.
Head office | New Zealand |
CEO | John Cullity |
Founded | 2013 |
Website | www.ebos.co.nz |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.